KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Inventory: 2010-2025

Historic Change in Inventory for Emergent BioSolutions (EBS) over the last 15 years, with Sep 2025 value amounting to $17.6 million.

  • Emergent BioSolutions' Change in Inventory fell 2.22% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year increase of 238.38%. This contributed to the annual value of $24.5 million for FY2024, which is 4183.33% up from last year.
  • Emergent BioSolutions' Change in Inventory amounted to $17.6 million in Q3 2025, which was down 28.74% from $24.7 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Change in Inventory peaked at $99.9 million during Q1 2021, and registered a low of -$45.7 million during Q4 2022.
  • For the 3-year period, Emergent BioSolutions' Change in Inventory averaged around $6.2 million, with its median value being $4.5 million (2024).
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 631.40% in 2022, then surged by 17,900.00% in 2024.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Change in Inventory stood at $8.6 million in 2021, then slumped by 631.40% to -$45.7 million in 2022, then skyrocketed by 43.98% to -$25.6 million in 2023, then soared by 57.03% to -$11.0 million in 2024, then dropped by 2.22% to $17.6 million in 2025.
  • Its last three reported values are $17.6 million in Q3 2025, $24.7 million for Q2 2025, and $2.2 million during Q1 2025.